Health services research: Persistence and compliance in antihypertensive drugs;Versorgungsforschung: Persistenz und compliance bei antihypertensiva

Pharmazeutische Zeitung

Volumn 152, Issue 14, 2007, Pages 62-68

  Schüssel, Katrin ^a   Leuner, Kristina ^b   Schulz, Martin ^a   Müller, Walter E ^b  

^a ABDA Bundesvereinigung Deutscher Apothekerverbande   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MOXONIDINE; NEBIVOLOL;

ARTICLE; HEALTH SERVICE; HUMAN; HYPERTENSION; MEDICAL PRACTICE; MEDICAL RESEARCH; MONOTHERAPY; PATIENT ATTITUDE; PATIENT COMPLIANCE;

EID: 34247620786     PISSN: 00317136     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Deutsche Hochdruckliga: Leitlinien für die Prävention, Erkennung, Diagnostik und Therapie der arteriellen Hypertonie der Deutschen Liga zur Bekämpfung des hohen Blutdruckes e.V., 2003. Quelle: www.leitlinien.net (04.01.2007).
2. Morisky, D. E., et al. Five year blood pressure control and mortality following health education for hypertensive patients. Am. J. Public Health 73 (1983) 153-162.
3. Sharma, A. M., et al. High prevalence and poor control of hypertension in primary care: cross-sectional study. J. Hypertens. 22 (2004) 479-486.
4. Sabate, E. (Ed.). Adherence to long-term therapies: evidence for action. Geneva, Switzerland, World Health Organization (2003). Quelle: http://www.emro.who.int/ncd/Publications/ad herence_report.pdf (am 04.01.2007).
5. Holland, R. (Ed.). Continuing Education Programme - Compliance, Adherence or Concordance - Who cares?, Proceedings of the community pharmacy section, World Congress of Pharmacy and Pharmaceutical Sciences, Cairo, Egypt, FIP (International Pharmaceutical Federation), 2005.
6. Paes, A. H., Bakker, A., Soe-Agnie, C. J. Measurement of patient compliance. Pharm. World Sci. 20 (1998) 73-77.
7. Steiner, J. F., Prochazka, A. V. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J. Clin. Epidemiol. 50 (1997) 105-116.
8. Klungel, O. H., et al. Agreement between self-reported antihypertensive drug us and pharmacy records in a population-based study in The Netherlands. Pharm. World Sci. 21, 5 (1999) 217-220.
9. Morisky, D. E., Green, L. W., Levine, D. M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med. Care 24 (1986) 67-74.
10. Morris, A. B., et al. Factors associated with drug adherence and blood pressure control in patients with hypertension. Pharmacotherapy 26 (2006) 483-492.
11. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index (2006). Quelle: http://www.whocc.no/atcddd (04. 01.2007).
12. WldO Wissenschaftliches Institut der Ortskrankenkassen und DIMDI Deutsches Institut für medizinische Dokumentation und Information (Hrsg.) Anatomisch-therapeutisch-chemische Klassifikation mit Tagesdosen - amtliche deutsche Fassung, Köln, 2006. Quelle: http://www.dimdi.de/dynamic/de/ klassi/downloadcenter/atcddd/vorgaenger/version2006/atc-ddd_amtlich_2006.pdf (am 04.01.2007).
13. Sikka, R., Xia, F., Aubert, R. E. Estimating medication persistency using administrative claims data. Am. J. Manag. Care. 11 (2005) 449-457.
14. Degli Esposti, E., et al. Long-term persistence with antihypertensive drugs in new patients. J. Hum. Hypertens. 16 (2002) 439-444.
15. Hasford, J., Mimran, A., Simons, W. R. A population-based European cohort study of persistence in newly diagnosed hypertensive patients. J. Hum. Hypertens. 16 (2002) 569-575.
16. Van Wijk, B. L., et al. Rate and determinants of 10-year persistence with antihypertensive drugs. J. Hypertens. 23 (2005) 2101-2107.
17. Chapman, R. H., et al. Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch. Intern. Med. 165 (2005) 1147-1152.
18. Dusing, R. Adverse events, compliance, and changes in therapy. Curr. Hypertens. Rep. 3 (2001) 488-492.
19. Lowry, K. P., et al. Intentional and unintentional nonadherence to antihypertensive medication. Ann. Pharmacother. 39 (2005) 1198-1203.
20. Cook, C. L., et al. Concordance among three self-reported measures of medication adherence and pharmacy refill records. J. Am. Pharm. Assoc. 45 (2005) 151-159.
21. Johnson, A. L., et al. Self-recording of blood pressure in the management of hypertension. Can. Med. Assoc. J. 119 (1978) 1034-1039.
22. Lee, J. K., Grace, K. A., Taylor, A. J. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA 296 (2006) 2563-2571.
23. Quinzler, R., et al. The frequency of inappropriate tablet splitting in primary care. Eur. J. Clin. Pharmacol. 62 (2006) 1065-1073.
24. Griese, N., Schulz, M. Beratung 2. Blutdruck fehlerfrei selbst bestimmen. Pharm. Ztg. 150, 38 (2005) 3400-3402 + 147-150 [Standardarbeitsanweisungen (SOP) »Blutdruckmessung in der Apotheke« und » Patientenberatung bei der Blutdruckselbstmessung« sowie Patienteninformationen »Blutdruckmessung am Handgelenk« beziehungsweise »Blutdruckmessung am Oberarm« unter http://www.abda.de/729.html].